| [Effect of long-acting garlic tablets "allicor" on the incidence of acute respiratory viral infections in children] 2003 · Allicor 600 mg/day (first stage) · Children aged 7–16 years | 600 mg | 150 days | 172 |
| The effect of garlic tablet on plasma lipids and platelet aggregation in nulliparous pregnants at high risk of preeclampsia 2001 · Garlet (garlic) group · Primigravidas in the third trimester with a positive roll-over test, at high risk of preeclampsia | 800 mg | — | 50 |
| [Effect of long-acting garlic tablets "allicor" on the incidence of acute respiratory viral infections in children] 2003 · Allicor 300 mg/day (second stage) · Children aged 10–12 years | 300 mg | 150 days | 42 |
| Garlic extract favorably modifies markers of endothelial function in obese patients -randomized double blind placebo-controlled nutritional intervention 2018 · garlic extract group · Obese adults; age and sex not reported | 400 mg | 90 days | — |
| Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study 2004 · high-AGE group · Patients diagnosed with colorectal adenomas | 2.4 mL | 1 year | 19 |
| Aged garlic extract has potential suppressive effect on colorectal adenomas in humans 2006 · active group · Patients with colorectal adenomas after removal of adenomas larger than 5 mm by polypectomy | 2.4 mL | 1 year | 19 |
| Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study 2004 · low-AGE group · Patients diagnosed with colorectal adenomas | 0.16 mL | 1 year | 18 |
| Aged garlic extract has potential suppressive effect on colorectal adenomas in humans 2006 · control group · Patients with colorectal adenomas after removal of adenomas larger than 5 mm by polypectomy | 0.16 mL | 1 year | 18 |
| Comparison of the therapeutic effects of Garcin(®) and fluconazole on Candida vaginitis 2015 · Garcin group · Women aged 18–44 with diagnosed Candida vaginitis | 1.5 g | 7 days | 55 |
| Evaluation of the Effect of Garlic Tablet as a Complementary Treatment for Patients with Diabetic Retinopathy 2022 · Garlic group · Adults with diabetic retinopathy and diabetic macular edema; mean age 61.91 years, 83.1% female | 1 g | 4 weeks | 45 |
| Effects of garlic on brachial endothelial function and capacity of plasma to mediate cholesterol efflux in patients with coronary artery disease 2017 · Garlic group · Men and women aged 25–75 with severe coronary artery disease after angioplasty | 800 mg | 90 days | 21 |
| Garlic supplementation attenuates cycling exercise-induced oxidative inflammation but fails to improve time trial performance in healthy adults 2023 · garlic supplementation · Physically active males, mean age 22.0 ± 4.8 years, without the listed cardiovascular, metabolic, musculoskeletal or neuromuscular conditions | 1 g | 4 weeks | 11 |
| The effect of 12-week garlic supplementation on symptom relief in overweight or obese women with knee osteoarthritis 2018 · Garlic group · Postmenopausal overweight or obese women with medically diagnosed knee osteoarthritis | 1 g | 12 weeks | — |
| Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension 2009 · 600 mg Allicor · Men with mild or moderate arterial hypertension | 600 mg | 8 weeks | 30 |
| [Hypotensive effect of long-acting garlic tablets allicor (a double-blind placebo-controlled trial)] 2002 · group 1 · Patients with mild or moderate hypertension | 600 mg | — | — |
| Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial 2013 · garlic-2 (g2) · Adults with uncontrolled hypertension, mean age 70±12 years; men and women | 480 mg | 12 weeks | — |
| An intervention study to prevent gastric cancer by micro-selenium and large dose of allitridum 2004 · intervention group · Adults aged 35–74 with at least one risk criterion: a history of stomach disorder, a family history of tumour, or smoking and/or alcohol consumption | 200 mg | 30 days | 2,526 |
| Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial 2019 · Garlic supplementation · Rural Chinese adults aged 35–64 at high risk of gastric cancer, with and without H pylori infection | 402 mg | 2665 days | 1,678 |
| Effect of Raw Crushed Garlic (Allium sativum L.) on Components of Metabolic Syndrome 2018 · Raw crushed garlic · Patients with metabolic syndrome | 200 mg/kg | 4 weeks | 40 |
| Prospective, randomized, placebo-controlled, two-arm study to evaluate the efficacy of coadministration of garlic as a hydrogen sulfide donor and tadalafil in patients with erectile dysfunction not responding to tadalafil alone - A pilot study 2024 · Group A · Men aged 22–62 with erectile dysfunction, normal penile Doppler findings, and a declining response after initially responding to tadalafil | 10 g | 4 weeks | 19 |
| Synergistic effect of Moringa oleifera and Allium sativum on BMI and lipid profile: A randomized controlled trial 2023 · Treatment group 2 (group C) · Patients with hyperlipidemia; age and sex not specified | 2 g | 45 days | 15 |
| Beneficial effects of aged garlic extract and coenzyme Q10 on vascular elasticity and endothelial function: the FAITH randomized clinical trial 2013 · AGE/CoQ10 · Asymptomatic Los Angeles County firefighters with intermediate cardiovascular risk and high occupational stress | 1.2 g | 1 year | — |
| Aged garlic extract preserves cutaneous microcirculation in patients with increased risk for cardiovascular diseases: A double-blinded placebo-controlled study 2019 · AGE · Adults with Framingham Risk Score ≥ 10 and increased risk for cardiovascular disease | 2.4 g | 1 year | — |
| Effects of garlic powder supplementation on insulin resistance, oxidative stress, and body composition in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial 2020 · treatment group · Patients with non-alcoholic fatty liver disease; age range and sex not reported | 1.6 g | 12 weeks | — |
| Garlic supplementation improves intestinal transit time, lipid accumulation product and cardiometabolic indices in subjects with metabolic syndrome: A randomized controlled trial 2023 · treatment group · Subjects with metabolic syndrome; age and sex not specified | 1.6 g | 90 days | — |
| Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension 2009 · 900 mg Kwai · Men with mild or moderate arterial hypertension | 900 mg | 8 weeks | 16 |
| [Hypotensive effect of long-acting garlic tablets allicor (a double-blind placebo-controlled trial)] 2002 · group 3 · Patients with mild or moderate hypertension | 900 mg | — | — |
| Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomised controlled trial 2010 · active treatment group · Patients with treated but uncontrolled hypertension receiving antihypertensive medication | 960 mg | 12 weeks | — |
| Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial 2013 · garlic-1 (g1) · Adults with uncontrolled hypertension, mean age 70±12 years; men and women | 240 mg | 12 weeks | — |
| Aged garlic extract reduces blood pressure in hypertensives: a dose-response trial 2013 · garlic-4 (g4) · Adults with uncontrolled hypertension, mean age 70±12 years; men and women | 960 mg | 12 weeks | — |
| Aged garlic extract with supplement is associated with increase in brown adipose, decrease in white adipose tissue and predict lack of progression in coronary atherosclerosis 2013 · AGE-S · Subjects evaluated for coronary artery calcium; age, sex, and specific condition are not stated | 250 mg | 1 year | — |
| Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension 2009 · 2400 mg Allicor · Men with mild or moderate arterial hypertension | 2.4 g | 8 weeks | 18 |
| [Hypotensive effect of long-acting garlic tablets allicor (a double-blind placebo-controlled trial)] 2002 · group 2 · Patients with mild or moderate hypertension | 2.4 g | — | — |
| Accumulation of Sulforaphane and Alliin in Human Prostate Tissue 2022 · Alliin (Kwai) plus placebo · Men aged 18–80 with BMI 19.5–35 kg/m² awaiting trans-perineal prostate biopsy, including men with suspected or diagnosed prostate cancer | 715 mg | 4 weeks | — |
| [Study of the antioxidant drug "Karinat" in patients with chronic atrophic gastritis] 2004 · Karinat · Patients with chronic multifocal atrophic gastritis | 300 mg | 26 weeks | 34 |
| [Study of an antioxidant dietary supplement "Karinat" in patients with benign breast disease] 2004 · Karinat · Patients with benign breast disease, including mastopathy | 300 mg | 26 weeks | 33 |
| Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus 2005 · garlic group · Patients with type 2 diabetes and newly diagnosed dyslipidemia | 600 mg | 12 weeks | 35 |
| Effects of Fermented Garlic Extract Containing Nitric Oxide Metabolites on Blood Flow in Healthy Participants: A Randomized Controlled Trial 2022 · FGE group · Healthy adults aged 19 years or older; the two study cohorts had mean ages of approximately 61 and 54 years | 450 mg | 1 day | 30 |
| [Use of allikor for the normalization of fibrinolysis and hemostasis in patients with chronic cerebrovascular diseases] 2001 · group 1 · Patients with cerebral atherosclerosis complicated by chronic cerebrovascular pathology; age and sex not reported | 600 mg | — | 15 |
| [Use of allikor for the normalization of fibrinolysis and hemostasis in patients with chronic cerebrovascular diseases] 2001 · group 2 · Patients with cerebral atherosclerosis complicated by chronic cerebrovascular pathology; age and sex not reported | 600 mg | — | 14 |
| Garlic supplementation and lipoprotein oxidation susceptibility 1993 · garlic supplement · 10 healthy volunteers | 600 mg | 2 weeks | 10 |
| Lipid-lowering effects of time-released garlic powder tablets in double-blinded placebo-controlled randomized study 2008 · Allicor-treated patients · Men aged 35–70 with mild hypercholesterolemia | 600 mg | 12 weeks | — |
| LDL-Cholesterol-Lowering Effects of a Dietary Supplement Containing Onion and Garlic Extract Used in Healthy Volunteers 2024 · Allium group · Adults aged 18–65 of both sexes with slightly elevated LDL cholesterol (100–190 mg/dL), described as healthy volunteers | 14 mg | 8 weeks | 33 |
| Aged garlic extract supplemented with B vitamins, folic acid and L-arginine retards the progression of subclinical atherosclerosis: a randomized clinical trial 2009 · AGE+S · Intermediate-risk adults, mean age 60 ± 9 years; 79% male | 250 mg | 1 year | — |
| Anti-atherosclerotic therapy based on botanicals 2013 · Allicor group · Asymptomatic men aged 40–74 with ultrasound evidence of early carotid atherosclerosis | 300 mg | 2 years | 93 |
| Efficacy of garlic (Allium sativum) on metabolic syndrome components in women with polycystic ovary syndrome: randomized controlled trial 2025 · garlic group · Women with PCOS and metabolic syndrome; reproductive-age adults, non-pregnant | 1 g | 8 weeks | 48 |
| The effect of aged garlic extract on the atherosclerotic process - a randomized double-blind placebo-controlled trial 2020 · AGE group · Adults aged 40–75 with Framingham risk score ≥10 and a positive coronary artery calcium score; high cardiovascular risk | 1.2 g | 1 year | 47 |
| Aged garlic extract improves adiponectin levels in subjects with metabolic syndrome: a double-blind, placebo-controlled, randomized, crossover study 2013 · AGE (Kyolic) · Men and women over 18 years old with metabolic syndrome | 1.2 g | 12 weeks | 46 |
| The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease 2010 · Allicor · Men and women aged 40–65 with documented coronary heart disease and serum cholesterol above 200 mg/dl | 300 mg | 1 year | 33 |
| Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients 2011 · Group 1 · Adults with diagnosed type 2 diabetes and fasting blood sugar above 126 mg/dl | 900 mg | 24 weeks | 30 |
| The favorable effects of garlic intake on metabolic profiles, hs-CRP, biomarkers of oxidative stress and pregnancy outcomes in pregnant women at risk for pre-eclampsia: randomized, double-blind, placebo-controlled trial 2015 · Garlic · Primigravida pregnant women aged 18–40 years at 27 weeks’ gestation with a positive roll-over test, at risk for pre-eclampsia | 400 mg | 9 weeks | 22 |
| Evaluating the effect of garlic extract on serum inflammatory markers of peritoneal dialysis patients: a randomized double-blind clinical trial study 2019 · intervention group (Garlic extract) · Adults aged 18–80 with end-stage renal disease receiving peritoneal dialysis | 800 mg | 8 weeks | 19 |
| Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba 2005 · Garlic oil supplementation · Healthy elderly adults, 67 ± 5.2 years; 6 men and 6 women | 1.5 g | 4 weeks | 12 |
| Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects 1993 · dried garlic powder (Sapec) · 12 healthy subjects | 900 mg | 2 weeks | 12 |
| Garlic supplementation attenuates cycling exercise-induced oxidative inflammation but fails to improve time trial performance in healthy adults 2023 · garlic supplementation · Physically active males, mean age 22.0 ± 4.8 years, without the listed cardiovascular, metabolic, musculoskeletal or neuromuscular conditions | 1 g | 4 weeks | 11 |
| Comparison of the efficacy and tolerance of a garlic preparation vs. bezafibrate 1992 · garlic preparation (Sapec, Kwai) · Patients with primary hyperlipoproteinaemia; age and sex not stated | 900 mg | 12 weeks | — |
| [Postprandial lipemia under treatment with Allium sativum. Controlled double-blind study of subjects with reduced HDL2-cholesterol] 1992 · garlic group · Adult men and women with reduced HDL2-cholesterol (men below 10 mg/dl; women below 15 mg/dl) | 900 mg | 6 weeks | — |
| [Does garlic influence rheologic properties and blood flow in progressive systemic sclerosis?] 2006 · dried garlic powder · Adult female inpatients with systemic sclerosis | 900 mg | 7 days | — |
| Therapy with garlic: results of a placebo-controlled, double-blind study 1990 · drug group · Hypercholesterolaemic out-patients; age and sex not reported | 900 mg | 120 days | — |
| Treatment of hyperlipidaemia with garlic-powder tablets. Evidence from the German Association of General Practitioners' multicentric placebo-controlled double-blind study 1990 · Garlic-powder group · Adults with hyperlipidaemia and total cholesterol and/or triglyceride values above 200 mg/dl | 800 mg | 16 weeks | — |
| The effect of garlic powder on human urinary cytokine excretion 2014 · 1 g garlic powder · Healthy volunteers | 1 g | 1 day | — |
| The effect of a garlic supplement on the pro-inflammatory adipocytokines, resistin and tumor necrosis factor-alpha, and on pain severity, in overweight or obese women with knee osteoarthritis 2018 · garlic group · Post-menopausal overweight or obese women aged 50–75 years with mild to moderate knee osteoarthritis | 1 g | 12 weeks | — |
| A randomized, double-blind, placebo-controlled clinical trial, evaluating the garlic supplement effects on some serum biomarkers of oxidative stress, and quality of life in women with rheumatoid arthritis 2020 · garlic group · Women with rheumatoid arthritis | 1 g | 8 weeks | — |
| The effect of garlic (Allium sativum) supplementation on the lipid parameters and blood pressure levels in women with polycystic ovary syndrome: A randomized controlled trial 2021 · Garlic supplementation · Women with polycystic ovary syndrome; age range not stated | 800 mg | 8 weeks | — |
| Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack 1993 · garlic group · Voluntary subjects with cerebrovascular risk factors and persistently increased platelet aggregation; age and sex not reported | 800 mg | 4 weeks | — |
| Can garlic reduce levels of serum lipids? A controlled clinical study 1993 · standardized garlic powder · Healthy adults, mean age 52 years, with serum total cholesterol ≥220 mg/dL | 900 mg | 12 weeks | — |
| Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men 1997 · 900 mg garlic/d + 12 g oil placebo/d · Men with moderate hypercholesterolemia | 900 mg | 12 weeks | — |
| Supplementation with aged garlic extract improves both NK and γδ-T cell function and reduces the severity of cold and flu symptoms: a randomized, double-blind, placebo-controlled nutrition intervention 2012 · aged garlic extract group · Healthy subjects; age and sex not reported | 2.56 g | 90 days | 60 |
| Effects of anethum graveolens and garlic on lipid profile in hyperlipidemic patients 2007 · Garlic group · Adults aged 31–78 with coronary artery disease and newly diagnosed hyperlipidemia | 800 mg | 6 weeks | 50 |
| Successful improved peripheral tissue perfusion was seen in patients with atherosclerosis after 12 months of treatment with aged garlic extract 2021 · AGE group · Adults aged 40–75 with atherosclerosis confirmed by cardiac CT and elevated cardiovascular risk | 2.4 g | 1 year | 46 |
| A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids 1996 · aged garlic extract · Moderately hypercholesterolemic men with cholesterol concentrations of 5.7–7.5 mmol/L (220–290 mg/dL) | 7.2 g | 26 weeks | 41 |
| Improved microvascular reactivity after aged garlic extract intake is not mediated by hydrogen sulfide in older adults at risk for cardiovascular disease: a randomized clinical trial 2022 · aged garlic extract (AGE) · Adults aged 67 ± 6 years with cardiovascular disease risk factors | 2.4 g | 1 day | 28 |
| Effect of garlic powder tablet on carotid intima-media thickness in patients with coronary artery disease: a preliminary randomized controlled trial 2013 · garlic group · Patients aged 25–75 years with coronary artery disease | 2.4 mg | 90 days | 27 |
| Aged Garlic Extract Reduces Low Attenuation Plaque in Coronary Arteries of Patients with Metabolic Syndrome in a Prospective Randomized Double-Blind Study 2016 · AGE group · Adults with metabolic syndrome; mean age 58.7 years, 71% men | 2.4 g | 354 days | 27 |
| Hypocholesterolemic effect of an enteric-coated garlic supplement 2001 · garlic supplement group · Adults with mild to moderate hypercholesterolemia who had failed or were not compliant with drug therapy | 9.6 mg | 12 weeks | 22 |
| Supplementation of garlic and coriander seed powder: Impact on body mass index, lipid profile and blood pressure of hyperlipidemic patients 2018 · garlic powder (GP) · Hyperlipidemic patients; age and sex not specified | 2 g | 40 days | 20 |
| Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis 2012 · Group D (6 capsules a day) · Adults with histologically confirmed chronic hepatitis and persistently elevated ALT and AST; most were infected with HBV | 300 mg | 6 weeks | 17 |
| Effect of combined supplementation of fish oil with garlic pearls on the serum lipid profile in hypercholesterolemic subjects 2005 · Combined fish oil and garlic pearls group · Adults aged 30–60 with hypercholesterolemia and total cholesterol above 220 mg/dl | 500 mg | 60 days | 16 |
| Oral post-exercise garlic extract supplementation enhances glycogen replenishment but does not up-regulate mitochondria biogenesis mRNA expression in human-exercised skeletal muscle 2024 · garlic trial · Healthy, physically active male university students, college-aged (mean age 21.4 years) | 2 g | 1 day | 12 |
| Comparison of therapeutic effects of garlic and d-Penicillamine in patients with chronic occupational lead poisoning 2012 · garlic group · Workers with chronic occupational lead poisoning at a car battery industry; age and sex not reported | 3.6 mg | 4 weeks | — |
| The effect of garlic powder on human urinary cytokine excretion 2014 · 3 g garlic powder · Healthy volunteers | 3 g | 1 day | — |
| A Single Meal Containing Raw, Crushed Garlic Influences Expression of Immunity- and Cancer-Related Genes in Whole Blood of Humans 2015 · garlic-containing meal · 17 human volunteers; age and sex not stated; no stated condition | 5 g | 1 day | — |
| Aged garlic extract supplementation modifies inflammation and immunity of adults with obesity: A randomized, double-blind, placebo-controlled clinical trial 2018 · AGE supplementation group · Adults with obesity; mean age 45.6 years | 3.6 g | 6 weeks | — |
| Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial 2020 · garlic powder supplement group · Patients with non-alcoholic fatty liver disease; age and sex not stated | 1.6 g | 12 weeks | — |
| Effects of garlic powder supplementation on metabolic syndrome components, insulin resistance, fatty liver index, and appetite in subjects with metabolic syndrome: A randomized clinical trial 2021 · garlic powder · subjects with metabolic syndrome; age and sex not stated | 1.6 g | 90 days | — |
| Accumulation of Sulforaphane and Alliin in Human Prostate Tissue 2022 · BroccoMax/GRN plus alliin (Kwai) · Men aged 18–80 with BMI 19.5–35 kg/m² awaiting trans-perineal prostate biopsy, including men with suspected or diagnosed prostate cancer | 715 mg | 4 weeks | — |
| Modulation of lipid profile by fish oil and garlic combination 1997 · Fish oil with garlic · Adults with lipid profile abnormalities and cholesterol levels >200; age and sex not reported | 1.2 g | 30 days | 40 |
| Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis 2012 · Group B (2 capsules a day) · Adults with histologically confirmed chronic hepatitis and persistently elevated ALT and AST; most were infected with HBV | 100 mg | 6 weeks | 22 |
| Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis 2012 · Group C (3 capsules a day) · Adults with histologically confirmed chronic hepatitis and persistently elevated ALT and AST; most were infected with HBV | 150 mg | 6 weeks | 21 |
| Synergistic effect of Moringa oleifera and Allium sativum on BMI and lipid profile: A randomized controlled trial 2023 · Treatment group 3 (group D) · Patients with hyperlipidemia; age and sex not specified | 2 g | 45 days | 15 |
| A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins 2006 · garlic supplementation · Disease-free people in a rural Chinese population; age and sex not specified | 400 mg | 2666 days | — |
| Effect of garlic and fish-oil supplementation on serum lipid and lipoprotein concentrations in hypercholesterolemic men 1997 · 900 mg garlic/d + 12 g fish oil/d · Men with moderate hypercholesterolemia | 900 mg | 12 weeks | — |
| A Randomized Controlled Trial of a Herbal Compound for Improving Metabolic Parameters in Diabetic Patients with Uncontrolled Dyslipidemia 2019 · intervention group · Adults with type 2 diabetes and dyslipidemia despite statin therapy; age and sex not specified | 600 mg | 12 weeks | 25 |